Cargando…
Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
As one of the main threats to human life (the fourth most dangerous and prevalent cancer), colorectal cancer affects many people yearly, decreases patients’ quality of life, and causes irreparable financial and social damages. In addition, this type of cancer can metastasize and involve the liver in...
Autores principales: | He, Xing, Lan, Huanrong, Jin, Ketao, Liu, Fanlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543914/ https://www.ncbi.nlm.nih.gov/pubmed/37790928 http://dx.doi.org/10.3389/fimmu.2023.1237764 |
Ejemplares similares
-
It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
por: Yao, Shiya, et al.
Publicado: (2023) -
Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
por: He, Xing, et al.
Publicado: (2023) -
From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?
por: Yao, Shiya, et al.
Publicado: (2023) -
Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective
por: Lan, Huanrong, et al.
Publicado: (2020) -
Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
por: Fang, Xingliang, et al.
Publicado: (2022)